Comparative Analysis of Tumor-Infiltrating Lymphocytes in a Syngeneic Mouse Model of Oral Cancer

被引:63
|
作者
Judd, Nancy P. [1 ]
Allen, Clint T. [1 ]
Winkler, Ashley E. [1 ]
Uppaluri, Ravindra [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, John Cochran VA Med Ctr, St Louis, MO 63110 USA
关键词
syngeneic model; oral cancer; tumor infiltrating lymphocytes; SQUAMOUS-CELL CARCINOMA; FOXP3(+) T-CELLS; CLASS-I ANTIGEN; DOWN-REGULATION; MURINE MODEL; HEAD; NECK; SUPPRESSION; MECHANISMS; BIOLOGY;
D O I
10.1177/0194599812442037
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective. To perform a comparative analysis of infiltrating immune cells in a newly developed C57BL/6 background syngeneic transplantable mouse oral cancer (MOC) model. Study Design/Setting. Scientific study in an academic medical center. Methods. Use of carcinogen-induced tumorigenesis, tissue culture, cell line transplantation, and flow cytometric analysis techniques. Results. Previously, the authors established a series of cell line models that displayed dichotomous growth phenotypes when transplanted into immunocompetent mice. They now show that the indolent growth pattern of the MOC1-generated tumors is associated with increased baseline and inducible major histocompatibility complex class I expression and increased CD8(+) T-cell infiltration into the tumor microenvironment. Conversely, the aggressive and metastatic pattern of MOC2-generated tumors has decreased basal and inducible class I expression and is associated with FOXP3(+)CD4(+) regulatory T-cell infiltration. Delayed primary tumor growth after targeted monoclonal antibody therapy of these FOXP3(+) regulatory cells further suggests that these immune cells contribute to the aggressive phenotype of MOC2. Conclusion. These data validate that key infiltrating immune cells identified here parallel findings in human head and neck cancer, making this newly developed syngeneic model a critical platform for the continued dissection of tumor-host interactions in head and neck cancer.
引用
收藏
页码:493 / 500
页数:8
相关论文
共 50 条
  • [41] The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer
    Li, Jun
    Wang, Jieyu
    Chen, Ruifang
    Bai, Yang
    Lu, Xin
    ONCOTARGET, 2017, 8 (09) : 15621 - 15631
  • [42] Tumor-infiltrating lymphocytes predict prognosis in early breast cancer
    Mao, Y.
    Qu, Q.
    Wu, J.
    Chen, X.
    Huang, O.
    Shen, K.
    BREAST, 2015, 24 : S101 - S101
  • [43] Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer
    Heikkinen, Ilkka
    Bello, Ibrahim O.
    Wahab, Awais
    Hagstrom, Jaana
    Haglund, Caj
    Coletta, Ricardo D.
    Nieminen, Pentti
    Makitie, Antti A.
    Salo, Tuula
    Leivo, Ilmo
    Almangush, Alhadi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (10) : 1392 - 1396
  • [44] Tumor-infiltrating lymphocytes for melanoma immunotherapy
    Kepp, Oliver
    Liu, Peng
    Zitvogel, Laurence
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [45] Tumor-Infiltrating Lymphocytes Clinical Experience
    Besser, Michal J.
    Shapira-Frommer, Ronnie
    Schachter, Jacob
    CANCER JOURNAL, 2015, 21 (06): : 465 - 469
  • [46] Role of tumor-infiltrating lymphocytes in Melanoma
    Cihan, Yasemin Benderli
    TURKISH JOURNAL OF PLASTIC SURGERY, 2019, 27 (01): : 39 - 40
  • [47] The biologic importance of tumor-infiltrating lymphocytes
    Hodi, F. Stephen
    Dranoff, Glenn
    JOURNAL OF CUTANEOUS PATHOLOGY, 2010, 37 : 48 - 53
  • [48] Tumor-infiltrating lymphocytes in the immunotherapy era
    Sterre T. Paijens
    Annegé Vledder
    Marco de Bruyn
    Hans W. Nijman
    Cellular & Molecular Immunology, 2021, 18 : 842 - 859
  • [49] CHARACTERIZATION OF HUMAN TUMOR-INFILTRATING LYMPHOCYTES
    GERVOIS, N
    PANDOLFINO, MC
    LETESSIER, E
    DIEZ, E
    JOTEREAU, F
    BULLETIN DU CANCER, 1988, 75 (07) : 721 - 721
  • [50] CLONING OF HUMAN TUMOR-INFILTRATING LYMPHOCYTES
    ZHOU, S
    MAO, N
    ZHANG, MW
    JIANG, FZ
    LI, XS
    TANG, PH
    DU, DL
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 766 - 766